New Moms Breastfed Longer During Pandemic
Health

New Moms Breastfed Longer During Pandemic

By Cara Murez HealthDay ReporterMONDAY, May 22, 2023 (HealthDay News) — Early in the COVID-19 pandemic, when shelter-in-place orders were ongoing, new moms tended to breastfeed their babies about two weeks longer than usual, new research shows.“Stay-at-home policies enabled parents to continue breastfeeding at home instead of returning to the workplace,” said study co-author Dr. Rita… […]

Geographic Atrophy: Caring for a Loved One Losing Their Sight
Health

Geographic Atrophy: Caring for a Loved One Losing Their Sight

By Linda Chernek Moore, as told to Keri WigintonWhether you live with someone or not, the role of caregiver can be all-consuming. But like they say before takeoff: Put your oxygen mask on first. In other words, you can’t care for others if you don’t care for yourself.I also caution people about being helicopter caregivers.… […]

My Life With Geographic Atrophy
Health

My Life With Geographic Atrophy

By Margret Krakauer, as told to Keri Wiginton I’ve recently switched hobbies from painting to writing. One of the first things I wrote for my memoir was: It’s a race between losing my vision and my hearing.I’m 79 and had cataract surgery a decade ago. That’s when my doctor diagnosed me with age-related macular degeneration (AMD).… […]

Early-Life Smartphone Use Tied to Poorer Mental Health in Gen Z
Health

Early-Life Smartphone Use Tied to Poorer Mental Health in Gen Z

May 18, 2023 – America’s fascination and dependence on smartphones seems to know no end – and if you think it’s common for kids to be staring at their screens as much as adults do, you’re right. Several studies have found that more kids are using smartphones and similar digital devices (like tablets) and at… […]

Breast Cancer Under 40: Q&A With Ann Partridge, MD, MPH
Health

Breast Cancer Under 40: Q&A With Ann Partridge, MD, MPH

By Ann H. Partridge, MD, MPH, as told to Alexandra Benisek In the WebMD webinar “Diagnosed Under 40: Breast Cancer’s Unique Impacts on Younger Women,” Ann Partridge, MD, MPH, from the Dana-Farber Cancer Institute and Harvard Medical School, answered viewer questions about breast cancer risk in young people, treatment options, recurrence, and more. This is dependent on… […]

Rare Disease Families Advocate For Change
Health

Rare Disease Families Advocate For Change

“We know that a rare disease diagnosis is a race against the clock.” – Patient advocate Kasey Woleben of McKinney, TX Will Woleben was hitting all his developmental milestones as he entered the toddler years. He was walking, active, social, and curious, says mom Kasey Woleben of McKinney, TX. Then around age 2 – for no clear… […]

FDA Approves First Pill to Treat Moderate-to-Severe Crohn’s
Health

FDA Approves First Pill to Treat Moderate-to-Severe Crohn’s

By Cara Murez HealthDay ReporterFRIDAY, May 19, 2023 (HealthDay News) — Patients with Crohn’s disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).Rinvoq is meant to treat adults with moderately to severely active Crohn’s disease who have not had success with TNF (tumor necrosis factor) blockers.… […]

Fat Growing Around Muscles Could Be a Silent Killer
Health

Fat Growing Around Muscles Could Be a Silent Killer

By Dennis Thompson HealthDay ReporterTHURSDAY, May 18, 2023 (HealthDay News) — It’s well known that it’s unhealthy to have belly fat accumulating around your abdominal organs, but there’s a more insidious form of fat that could be even more hazardous to your health, a new study says.Fat that infiltrates your muscles appears to dramatically increase your… […]

Weight Loss Drug Helps Half of Teens in Study Tackle Obesity
Health

Weight Loss Drug Helps Half of Teens in Study Tackle Obesity

May 19, 2023 — Nearly half of teens given the weight loss drug semaglutide (Wegovy) managed to lose enough weight to drop below the clinical threshold for obesity, a new study shows. By comparison, only 12.1% of adolescents with obesity given a placebo in the 68-week trial dropped below the threshold. Semaglutide belongs to a class of… […]